S3E Start 2024 | Meet the research team: OncoMagnetoSweep
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
OncoMagnetoSweep is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/5gF6SJ_s994?feature=shared
“We enrolled in S3E Start because we wanted to check if our our technology had the potential to be commercialized. Thanks to this program and the expert support we've received from our mentor, we've learned how to turn our idea into a startup and how to introduce it to a wide network of investors." — Marta Laranjeira
This project is pioneered by researchers from i3S - Institute for Research and Innovation in Health and CBQF - Center for Biotechnology and Fine Chemistry, including: Marta Laranjeira, Diana R. Fonseca, Luísa Fialho and Natacha Rosa. This team have developed a magnetic extracorporeal device able to remove circulating tumor cells (CTCs) from whole blood to improve metastatic cancer treatment and prevent early metastasis formation for high-risk patients, significantly enhancing prognosis and survival rates.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Start 2024 | Meet the research team: NemAway
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
NemAway is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/KN6NdopD7KM?feature=shared
“We decided to join S3E Start because we needed a push in our transfer of knowledge from academia to industry. It's been a very important experience for us and we've learned a lot from this program — from how to communicate to investors to how to build a business project from scratch." — Cláudia Vicente
This project is pioneered by researchers from University of Évora, including: Cláudia Vicente, Margarida Espada, Pedro Barbosa and Madalena Mendonça. With the aim of developing bio-based and sustainable solutions to combat plant-parasitic nematodes, they've created NemAway, a fast and efficient action bionematicide that helps to protect crops and foster environmentally-friendly practices in agriculture.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Start 2024 | Meet the research team: GENESIS
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
GENESIS is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/TihCZ_82m8I?feature=shared
“It was wonderful to participate in this program! This experience has helped us to jump from the research stage into starting a company." — Diogo Silva
This project is pioneered by researchers the Faculty of Engineering at University of Porto (FEUP) in collaboration INEGI, including: Alexandra Rodrigues Pinto, Diogo Silva, Helder Xavier Nunes and Lucas Marcon. Their main focus is to help the maritime sector reduce their dependency on oil-based fuel engines and in turn adopt greener and environmentally-friendly practices thanks to GENESIS, a safe plug-and-play off-grid production system that assures clean, pure hydrogen and borate with high value.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Start 2024 | Meet the research team: EcoPlan
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
EcoPlan is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/rGSG01MOXnQ?feature=shared
“The most important lesson we've learned during S3E Start is how to pitch our idea, how to effectively convince diverse audiences that our business idea, our application, is worth investing on." — Marius Kriukovas
This project is pioneered by researchers from Vilnius University, and it aims to simplify the material selection process for the Architecture, Engineering and Construction (AEC) sector through AI-powered recommendations and a comprehensive database, and in turn enhancing sustainability for architects, engineers and construction firms while helping them advance towards greener and more efficient building practices. The EcoPlan team is led by Marius Kriukovas and Greta Cerskute.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Start 2024 | Meet the research team: BreastScreening-AI
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
BreastScreening-AI is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/VppWuptBg0I?feature=shared
“We joined S3E Start to help us prepare for the EIC Accelerator and, as we expected, it has been a great opportunity for us to grow. We have developed our project plan to bring our solution into the market, and we now also feel ready to start pitching for funding." — Francisco Maria Calisto
This project is pioneered by researchers from University of Lisbon's Instituto Superior Técnico and University of Coimbra, and it focuses on developing advanced AI-driven diagnostic tools that integrate mammography, ultrasound, and MRI data to enhance breast cancer detection accuracy, and in turn help radiologists reducing diagnostic times and minimizing false positives and negative. The full BreastScreening-AI team includes: Francisco Maria Calisto, Carlos Santiago and André Fadiga.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Reverse: University Hospital Cologne and Tero join forces to implement Big Data management systems in hospital settings
Through the S3E Reverse program, University Hospital Cologne and Greek startup Tero are coming together to devise effective management systems for highly sensitive clinical data.
Part of the EU-funded project South3E, Reverse is a dedicated business brokerage program connecting corporate challenges with deep tech solutions developed by scaleups and SMEs from Southern Europe. The program is built on a successful open innovation methodology designed to foster collaboration and drive technological advancement.
The challenge
The University Hospital Cologne (Uniklinik Köln) is one of Germany’s most outstanding medical centers, internationally renowned for its innovation-driven research powering some of the most disruptive solutions in modern healthcare. Among its many successes, the interdisciplinary teams at Cologne are acclaimed for leading up the development of new treatments for patients underpinned by robust scientific research, especially in the area of rare diseases.
In order to facilitate the safe exchange of clinical data and support informed clinical decision-making at the Hospital, they were looking to implement a robust data-protecting systems for its intra- and interhospital infrastructures, which is crucial for ensuring that sensitive patient information is transmitted securely between departments and partner institutions, minimizing the risk of data breaches and unauthorized access.
Without such protections, the hospital could face significant risks, including compromised patient privacy, potential legal liabilities, and the erosion of trust in the healthcare system. Additionally, delays or inaccuracies in clinical decision-making due to insecure or inefficient data exchange could lead to suboptimal patient outcomes.
With this in mind, the University Hospital Cologne signed up to S3E Reverse as a Challenger to find a specialist tech startup capable of providing the ultimate solution to their key need.
After receiving Cologne’s challenge, Reverse broker Epaminondas Christophilopoulos was assigned to the mission of finding the best match for them. He is the UNESCO Chair on Futures Research at the Institute of Technology and Research (FORTH), and holds an impressive track record of providing foresight, strategy, innovation and long-term planning advisory in R&D activities carried by public and private corporations.
The solution
Greek startup Tero specialises in developing technologies aimed at improving environmental and social welfare. Their main focus is to provide innovative solutions for environmental monitoring, pollution control and sustainable development, and they offer expertise in managing projects that integrate advanced technology with environmental science.
However, in addition to their environmental focus, Tero also works on projects that have a significant social impact. This includes initiatives that enhance public health, safety, and community well-being through the application of their ICT solutions, making them the perfect Solver to tackle University Hospital Cologne's challenge: to design a high-tech platform for big data management and the support of secure information exchange in a hospital setting.
By joining S3E Reverse, Tero’s team of professionals brought in their expertise and knowledge to help Cologne’s clinicians and researchers to implement a big data management system to enhance the protection of clinical data by centralizing and securing patient information across various platforms. This approach will enable the hospital to monitor data access, detect potential breaches in real-time, and enforce stringent security protocols. Additionally, the system would ensure that only authorized personnel can access sensitive information, reducing the risk of unauthorized data exposure.
Overall, by collaborating hand-in-hand with Tero, the Hospital will be able to manage large volumes of clinical data efficiently, as well as improving their compliance with regulatory standards, safeguarding patient privacy and maintaining trust.
A call to innovators: apply to be a Solver and join the Deep Tech revolution!
This partnership between University Hospital Cologne and Tero is a testament to the power of collaboration and innovation to tackle industry challenges.
We invite all Deep Tech startups and SMEs based in Southern Europe to explore our challenges and join the S3E Reverse program as a Solver. The deadline for applications is 31 October 2024.
For more information and to apply, click here.
S3E Start 2024 | Meet the research team: Blood2Power
At this year's S3E Start Open Day, celebrated at the Tivoli BBVA Theatre in Lisbon, we interviewed the participating research teams to find out more about their projects and how they’re planning to implement the knowledge they’ve gained through our program to take their innovation from the lab to the the market.
Blood2Power is one of the 14 teams that was selected to join the 2024 edition of S3E Start, our program of support for deep tech research and entrepreneurship in Southern Europe, coordinated by our South3E partner HiSeedTech. Watch below the full interview to hear all about their work and their experience on Start!
https://youtu.be/SEaZOKtOs44?feature=shared
“This kind of program is very important for researchers because we get to learn a lot of new things beyond our scientific knowledge; our technology will only be fruitful if it goes to the patient, and thanks to S3E Start we are now closer to achieving that” — Andreia Pereira.
This project is pioneered by researchers from i3S - Instituto de Investigação e Inovação em Saúde, and it revolves around the development of a system that harnesses electrical energy from the movement of blood and other body fluids to power medical devices. The full Blood2Power team includes: Inês Gonçalves, Andreia Trindade Pereira, Daniela Sousa, Herbert Middleton and Salomé Luís.
Want to meet the rest of the teams? Access the full playlist featuring interviews with other participating teams.
If you missed the S3E Start Open Day, you can watch the full livestream recording with all the teams' pitches or our event recap for the top highlights.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Reverse: University Hospital Cologne and CNT set on a mission to revolutionize medical research
Through the S3E Reverse program, University Hospital Cologne and Greek startup Creative Novel Technologies (CNT) are joining forces to develop AI-powered tools that can help researchers and clinicians bring new solutions to patients faster.
Part of the EU-funded project South3E, Reverse is a dedicated business brokerage program connecting corporate challenges with deep tech solutions developed by scaleups and SMEs from Southern Europe. The program is built on a successful open innovation methodology designed to foster collaboration and drive technological advancement.
The challenge
The University Hospital Cologne (Uniklinik Köln) is one of Germany’s most outstanding medical centers, internationally renowned for its innovation-driven research powering some of the most disruptive solutions in modern healthcare. Among its many successes, the interdisciplinary teams at Cologne are acclaimed for leading up the development of new treatments for patients underpinned by robust scientific research, especially in the area of rare diseases.
With the amount of research being produced by medical and healthcare experts, the university hospital has been looking at appropriate techniques to develop search strategies for systematic reviews of medical research. One of the main challenges that researchers encounter during their investigative processes is having to sift through multiple databases and sources of scientific literature, making it extremely time and resource intensive.
With this in mind, the University Hospital Cologne signed up to S3E Reverse as a Challenger to find a specialist tech startup capable of providing the ultimate solution to their key need.
After receiving Cologne’s challenge, Reverse broker Epaminondas Christophilopoulos was assigned to the mission of finding the best match for them. He is the UNESCO Chair on Futures Research at the Institute of Technology and Research (FORTH), and holds an impressive track record of providing foresight, strategy, innovation and long-term planning advisory in R&D activities carried by public and private corporations.
The solution
With a clear mission to leverage the full capabilities of IoT technologies to help others innovate, Thessaloniki-based startup CNT stood out as the most fitting Solver to tackle two challenges submitted by University Hospital Cologne: to develop sustainable search frameworks to support medical and clinical researchers in their day-to-day investigative work.
Dimitrios Tektonidis is the brain behind CNT's innovative solutions, a Computer Science expert leading a large network of specialists to create new products, services and integrated IT solutions — from the implementation of Internet Systems Management all the way to the creation of tailored Cloud-based systems.
By joining S3E Reverse, CNT’s team of professionals brought in their expertise and knowledge to help Cologne’s researchers accelerate their discoveries, bringing them closer to finding solutions to some of the most pressing health issues they’re dealing with.
In order to tackle the challenge, CNT has offered their very own AI-powered semantic search services supported by the in-house developed ONAR framework, which has been developed as part of long collaborations with industry and research organisations, and previously validated in a number of business and use cases. This will help medical researchers minimize their paper scouting time, accelerating the speed in which life science researchers gain insights.
Thanks to CNT’s state-of-the-art IoT approach, this powerful collaboration with University Hospital Cologne is set to revolutionize medical research in academia, and in turn make a positive impact on the lives of many patients whilst paving the way for the future of healthcare innovation.
A call to innovators: apply to be a Solver and join the Deep Tech revolution!
This partnership between University Hospital Cologne and CNT is a testament to the power of collaboration and innovation to tackle industry challenges.
We invite all Deep Tech startups and SMEs based in Southern Europe to explore our challenges and join the S3E Reverse program as a Solver. The deadline for applications is 31 October 2024.
For more information and to apply, click here.
S3E Charge 2024 | Meet the startup: Nanomik Biotechnology
Nanomik Biotechnology is one of the 17 startups selected to participate in the 2024 edition of S3E Charge, the EU-funded accelerator program fostering deep tech innovation and entrepreneurship in Southern Europe.
We spoke with Arda Örçen, co-founder and CTO at Nanomik, to learn more about how this startup based in Istanbul is developing biotechnology solutions for multiple industries — from agriculture all the way to construction.
https://youtu.be/-Y_KFAuq2G8
Hi Arda! Tell us about Nanomik, the mission behind the business and the technology you’ve developed.
Nanomik Biotechnology is based in Istanbul, Türkiye, and it was founded in 2017. We are specialists in developing microcapsulation technology which enables the use of biological molecules to as biopesticide or bioprotector in various industries.
We started operating within the agriculture industry, offering a crop protection product, and we have now grown our product portfolio across the whole food supply chain, and we are even present in the construction industry. So, essentially, we consider Nanomik as the producer of advanced biologics for various industries.
Why have you decided to enrol in the S3E Charge accelerator?
From our previous experience, the Mediterranean region is very important from different aspects. From agricultural production to the whole food supply chain, it's very productive and tend to use biologics more and more.
The Mediterranean region and the whole of Southern Europe is very important for us, as a key market, which is why we chose to enter the S3E Charge accelerator program.
Also, as a deep tech company reaching a scaleup level, we are now in need of direct solutions and guidance, like IP protection and funding support, and this program can help us progress in each of these subjects.
What are the key ambitions for Nanomik? Where would you like to see the business in 5 years?
We want to penetrate into the global market with our technologies. For my team and I, the main focus is to establish networks with European and US partners, and to continue leveraging our existing geographical advantage towards the Middle East.
So, once we manage to integrate our solutions across different industries in all these regions, we want to create our large scale production facility with global reach — that's our ultimate vision.
Follow South3E on X and LinkedIn
Subscribe to our newsletter
S3E Charge 2024 | Meet the startup: Ecobubble
Ecobubble is one of the 17 startups selected to participate in the 2024 edition of S3E Charge, the EU-funded accelerator program fostering deep tech innovation and entrepreneurship in Southern Europe.
We spoke with Nicola Nescatelli, founder and project manager at Ecobubble, to learn more about how this Italian startup is optimising resource management in agriculture through Plantiverse, their latest greentech solution powered by plants to promote planet-friendlier ways of using natural resources.
https://youtu.be/lOXb_PdAcRE
Hi Nicola! Tell us about Ecobubble, the mission behind the business and the technology you’ve developed.
Ecobubble is a green tech startup based in Rome, and it was founded in 2019. Through Plantiverse, our most recent initiative, our mission is to optimise resource management in the agriculture sector by enabling plants to directly communicate their needs to automation systems embedded in agricultural and farming practices. For this, we've developed technologies that use multispectral analysis, advanced sensor technology and artificial intelligence to achieve more efficient and sustainable agriculture.
How would you describe your entrepreneurship journey so far?
Our journey has been primarily driven by passion, which has supported us to manage our mistakes and challenges more easily. We have also focused on creating and maintaining a collaborative and positive environment across our team, while being very objective-oriented.
Why have you decided to enrol in the S3E Charge accelerator?
We chose the S3E Charge accelerator to get the opportunity to grow and scale our technology within a dynamic and supported ecosystem, and we are particularly interested in fundraising support.
What are the key ambitions for Ecobubble? Where would you like to see the business in 5 years?
Our objective is to grow our business in Europe, starting with high revenue crop production, like vineyards, vertical farming, hydroponics and agrivoltaic systems.
After that, we would like to reach more extensive scale application through the development of our virtualisation component; this approach allows us to support a wide range of agricultural environments, from small to large scale, and significantly contribute to the fight against the climate change and promoting greater sustainability in the use of natural resources.